Endogenous glucocorticoid receptor signaling drives rhythmic changes in human T-cell subset numbers and the expression of the chemokine receptor CXCR4

FASEB Journal

Volumn 28, Issue 1, 2014, Pages 67-75

  Besedovsky, Luciana ^a,b   Born, Jan ^a   Lange, Tanja ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Circadian rhythm; Cortisol; CXCL12

Indexed keywords

ADRENALIN; ALDOSTERONE; CHEMOKINE RECEPTOR CXCR4; CORTICOTROPIN; GLUCOCORTICOID RECEPTOR; GROWTH HORMONE; HYDROCORTISONE; METYRAPONE; MIFEPRISTONE; NORADRENALIN; PLACEBO; PROLACTIN; STROMAL CELL DERIVED FACTOR 1;

ADRENALIN BLOOD LEVEL; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL HOMING; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; MALE; MEMORY T LYMPHOCYTE; NIGHT SLEEP; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SIDE EFFECT; SIGNAL TRANSDUCTION; SLEEP STAGE; T LYMPHOCYTE SUBPOPULATION; CONTROLLED CLINICAL TRIAL; CXCL12; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; YOUNG ADULT;

CIRCADIAN RHYTHM; CORTISOL; CXCL12;

ADULT; CHEMOKINE CXCL12; CIRCADIAN RHYTHM; FEMALE; FLOW CYTOMETRY; HUMANS; HYDROCORTISONE; MALE; METYRAPONE; MIFEPRISTONE; RECEPTORS, CXCR4; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 84894569166     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-237958     Document Type: Article

References (53)

1. Kawate, T., Abo, T., Hinuma, S., and Kumagai, K. (1981) Studies of the bioperiodicity of the immune response. II. Co-variations of murine T and B cells and a role of corticosteroid. J. Immunol. 126, 1364-1367
2. Pelegri, C., Vilaplana, J., Castellote, C., Rabanal, M., Franch, A., and Castell, M. (2003) Circadian rhythms in surface molecules of rat blood lymphocytes. Am. J. Physiol. Cell Physiol. 284, C67-C76
3. Scheiermann, C., Kunisaki, Y., and Frenette, P. S. (2013) Circadian control of the immune system. Nat. Rev. Immunol. 13, 190-198
4. Born, J., Lange, T., Hansen, K., Molle, M., and Fehm, H. L. (1997) Effects of sleep and circadian rhythm on human circulating immune cells. J. Immunol. 158, 4454-4464
5. Dimitrov, S., Benedict, C., Heutling, D., Westermann, J., Born, J., and Lange, T. (2009) Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood 113, 5134-5143
6. Fauci, A. S. (1975) Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow. Immunology 28, 669-680
7. Fauci, A. S., Murakami, T., Brandon, D. D., Loriaux, D. L., and Lipsett, M. B. (1980) Mechanisms of corticosteroid action on lymphocyte subpopulations. VI. Lack of correlation between glucocorticosteroid receptors and the differential effects of glucocorticosteroids on T-cell subpopulations. Cell. Immunol. 49, 43-50
8. Wang, J., Harada, A., Matsushita, S., Matsumi, S., Zhang, Y., Shioda, T., Nagai, Y., and Matsushima, K. (1998) IL-4 and a glucocorticoid up-regulate CXCR4 expression on human CD4 T lymphocytes and enhance HIV-1 replication. J. Leukoc. Biol. 64, 642-649
9. Okutsu, M., Ishii, K., Niu, K. J., and Nagatomi, R. (2005) Cortisolinduced CXCR4 augmentation mobilizes T lymphocytes after acute physical stress. Am. J. Physiol. 288, R591-R599
10. Reul, J. M., and de Kloet, E. R. (1985) Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117, 2505-2511
11. Kalman, B. A., and Spencer, R. L. (2002) Rapid corticosteroiddependent regulation of mineralocorticoid receptor protein expression in rat brain. Endocrinology 143, 4184-4195
12. Caulfield, J., Fernandez, M., Snetkov, V., Lee, T., and Hawrylowicz, C. (2002) CXCR4 expression on monocytes is up-regulated by dexamethasone and is modulated by autologous CD3 T cells. Immunology 105, 155-162
13. Curnow, S. J., Wloka, K., Faint, J. M., Amft, N., Cheung, C. M., Savant, V., Lord, J., Akbar, A. N., Buckley, C. D., Murray, P. I., and Salmon, M. (2004) Topical glucocorticoid therapy directly induces up-regulation of functional CXCR4 on primed T lymphocytes in the aqueous humor of patients with uveitis. J. Immunol. 172, 7154-7161
14. Rimmele, U., Besedovsky, L., Lange, T., and Born, J. (2013) Blocking mineralocorticoid receptors impairs, blocking glucocorticoid receptors enhances memory retrieval in humans. Neuropsychopharmacology 38, 884-894
15. Rechtschaffen, A., and Kales, A. (1968) A Manual of Standardized Terminology, Techniques and Scoring System for Sleep of Human Subjects, U.S. Goverment Printing Office, Washington, DC
16. Gower, D. B. (1974) Modifiers of steroid-hormone metabolism: a review of their chemistry, biochemistry and clinical applications. J. Steroid. Biochem. 5, 501-523
17. Rigel, D. F., Fu, F., Beil, M., Hu, C. W., Liang, G., and Jeng, A. Y. (2010) Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: comparison with the 11-hydroxylase inhibitor metyrapone. J. Pharmacol. Exp. Ther. 334, 232-243
18. Besedovsky, L., Lange, T., and Born, J. (2012) Sleep and immune function. Pflügers Arch. 463, 121-137
19. Cermakian, N., Lange, T., Golombek, D., Sarkar, D., Nakao, A., Shibata, S., and Mazzoccoli, G. (2013) Crosstalk between the circadian clock circuitry and the immune system. Chronobiol. Int. 30, 870-888
20. Ackermann, K., Revell, V. L., Lao, O., Rombouts, E. J., Skene, D. J., and Kayser, M. (2012) Diurnal rhythms in blood cell populations and the effect of acute sleep deprivation in healthy young men. Sleep 35, 933-940
21. Lee, B., Sharron, M., Montaner, L. J., Weissman, D., and Doms, R. W. (1999) Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. U. S. A. 96, 5215-5220
22. Thomson, S. P., McMahon, L. J., and Nugent, C. A. (1980) Endogenous cortisol: a regulator of the number of lymphocytes in peripheral blood. Clin. Immunol. Immunopathol. 17, 506-514
23. Trifonova, S. T., Zimmer, J., Turner, J. D., and Muller, C. P. (2013) Diurnal redistribution of human lymphocytes and their temporal associations with salivary cortisol. Chronobiol. Int. 30, 669-681
24. Gaillard, R. C., Riondel, A., Muller, A. F., Herrmann, W., and Baulieu, E. E. (1984) RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc. Natl. Acad. Sci. U. S. A. 81, 3879-3882
25. Bertagna, X., Escourolle, H., Pinquier, J. L., Coste, J., Raux-Demay, M. C., Perles, P., Silvestre, L., Luton, J. P., and Strauch, G. (1994) Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation. J. Clin. Endocrinol. Metab. 78, 375-380
26. Laue, L., Lotze, M. T., Chrousos, G. P., Barnes, K., Loriaux, D. L., and Fleisher, T. A. (1990) Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects. J. Clin. Endocrinol. Metab. 71, 1474-1480
27. Bertagna, X., Basin, C., Picard, F., Varet, B., Bertagna, C., Hucher, M., and Luton, J. P. (1988) Peripheral antiglucocorticoid action of RU 486 in man. Clin. Endocrinol. (Oxf.) 28, 537-541
28. Garrel, D. R., Moussali, R., De, O. A., Lesiege, D., and Lariviere, F. (1995) RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism. J. Clin. Endocrinol. Metab. 80, 379-385
29. Stephenson, R. P. (1997) A modification of receptor theory. 1956. Br. J. Pharmacol. 120, 106-120
30. Fryer, C. J., Kinyamu, H. K., Rogatsky, I., Garabedian, M. J., and Archer, T. K. (2000) Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells. J. Biol. Chem. 275, 17771-17777
31. Zhang, S., Jonklaas, J., and Danielsen, M. (2007) The glucocorticoid agonist activities of mifepristone (RU486) and progesterone are dependent on glucocorticoid receptor levels but not on EC50 values. Steroids 72, 600-608
32. Johanssen, S., and Allolio, B. (2007) Mifepristone (RU 486) in Cushing's syndrome. Eur. J. Endocrinol. 157, 561-569
33. Laue, L., Chrousos, G. P., Loriaux, D. L., Barnes, K., Munson, P., Nieman, L., and Schaison, G. (1988) The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man. J. Clin. Endocrinol. Metab. 66, 290-293
34. Besedovsky, L., Born, J., and Lange, T. (2012) Blockade of mineralocorticoid receptors enhances naive T-helper cell counts during early sleep in humans. Brain Behav. Immun. 26, 1116-1121
35. Miller, A. H., Spencer, R. L., Hassett, J., Kim, C., Rhee, R., Ciurea, D., Dhabhar, F., McEwen, B., and Stein, M. (1994) Effects of selective type I and II adrenal steroid agonists on immune cell distribution. Endocrinology 135, 1934-1944
36. Ottaway, C. A., and Husband, A. J. (1992) Central nervous system influences on lymphocyte migration. Brain Behav. Immun. 6, 97-116
37. Castinetti, F., Brue, T., and Conte-Devolx, B. (2012) The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome. Curr. Opin. Endocrinol. Diabetes. Obes. 19, 295-299
38. Feelders, R. A., and Hofland, L. J. (2013) Medical treatment of Cushing's disease. J. Clin. Endocrinol. Metab. 98, 425-438
39. Morgan, F. H., and Laufgraben, M. J. (2013) Mifepristone for management of Cushing's syndrome. Pharmacotherapy 33, 319-329
40. Bartholome, B., Spies, C. M., Gaber, T., Schuchmann, S., Berki, T., Kunkel, D., Bienert, M., Radbruch, A., Burmester, G. R., Lauster, R., Scheffold, A., and Buttgereit, F. (2004) Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J. 18, 70-80
41. Baus, E., Van, L. F., Andris, F., Rolin, S., Urbain, J., and Leo, O. (2001) Dexamethasone increases intracellular cyclic AMP concentration in murine T lymphocyte cell lines. Steroids 66, 39-47
42. Cole, S. W., Jamieson, B. D., and Zack, J. A. (1999) cAMP up-regulates cell surface expression of lymphocyte CXCR4: implications for chemotaxis and HIV-1 infection. J. Immunol. 162, 1392-1400
43. Ghosh, M. C., Baatar, D., Collins, G., Carter, A., Indig, F., Biragyn, A., and Taub, D. D. (2009) Dexamethasone augments CXCR4-mediated signaling in resting human T cells via the activation of the Src kinase Lck. Blood 113, 575-584
44. Cox, J. H., and Ford, W. L. (1982) The migration of lymphocytes across specialized vascular endothelium. IV. Prednisolone acts at several points on the recirculation pathways of lymphocytes. Cell. Immunol. 66, 407-422
45. Mazo, I. B., Honczarenko, M., Leung, H., Cavanagh, L. L., Bonasio, R., Weninger, W., Engelke, K., Xia, L., McEver, R. P., Koni, P. A., Silberstein, L. E., and von Andrian, U. H. (2005) Bone marrow is a major reservoir and site of recruitment for central memory CD8 T cells. Immunity 22, 259-270
46. Mendez-Ferrer, S., Lucas, D., Battista, M., and Frenette, P. S. (2008) Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452, 442-447
47. Kollet, O., Vagima, Y., D'Uva, G., Golan, K., Canaani, J., Itkin, T., Gur-Cohen, S., Kalinkovich, A., Caglio, G., Medaglia, C., Ludin, A., Lapid, K., Shezen, E., Neufeld-Cohen, A., Varol, D., Chen, A., and Lapidot, T. (2013) Physiologic corticosterone oscillations regulate murine hematopoietic stem/progenitor cell proliferation and CXCL12 expression by bone marrow stromal progenitors. [E-pub ahead of print] Leukemia doi: 10.1038/leu.2013.154.
48. Bai, Z., Hayasaka, H., Kobayashi, M., Li, W., Guo, Z., Jang, M. H., Kondo, A., Choi, B. I., Iwakura, Y., and Miyasaka, M. (2009) CXC chemokine ligand 12 promotes CCR7-dependent naive T cell trafficking to lymph nodes and Peyer's patches. J. Immunol. 182, 1287-1295
49. Sackstein, R., and Borenstein, M. (1995) The effects of corticosteroids on lymphocyte recirculation in humans: analysis of the mechanism of impaired lymphocyte migration to lymph node following methylprednisolone administration. J. Investig. Med. 43, 68-77
50. Stefanski, V., Peschel, A., and Reber, S. (2003) Social stress affects migration of blood T cells into lymphoid organs. J. Neuroimmunol. 138, 17-24
51. Di Rosa, F. (2009) T-lymphocyte interaction with stromal, bone and hematopoietic cells in the bone marrow. Immunol. Cell Biol. 87, 20-29
52. Feuerer, M., Beckhove, P., Garbi, N., Mahnke, Y., Limmer, A., Hommel, M., Hammerling, G. J., Kyewski, B., Hamann, A., Umansky, V., and Schirrmacher, V. (2003) Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat. Med. 9, 1151-1157
53. Di Rosa, F., and Pabst, R. (2005) The bone marrow: a nest for migratory memory T cells. Trends Immunol. 26, 360-366